Min MIn Qin
Chief Tech/Sci/R&D Officer presso LEPU BIOPHARMA CO., LTD.
Profilo
Min MIn Qin occupies the position of Chief Technology Officer & Senior Vice President for Lepu Biopharma Co., Ltd.
and Senior Vice President at Shanghai Miracogen, Inc. (a subsidiary of Lepu Biopharma Co., Ltd.).
Dr. Qin is also Senior Vice President at Shanghai Miracogen, Inc.
In the past Dr. Qin occupied the position of Chief Technology Officer at Shanghai Jmt Bio Co. Ltd., Chief Technology Officer & Senior Vice President of Zhejiang Teruisi Pharmaceutical Co., Ltd., Chief Science Officer at Jiangsu Pacific Meinuoke Pharmaceutical Co. Ltd., Senior Director-Process Development at BioMarin Pharmaceutical, Inc., Vice President at Wuxi Biologics (Cayman), Inc. and Senior Vice President at HBM Holdings Ltd.
Min MIn Qin received an undergraduate degree from Northwest A&F University and a doctorate from the University of Wisconsin.
Posizioni attive di Min MIn Qin
Società | Posizione | Inizio |
---|---|---|
LEPU BIOPHARMA CO., LTD. | Chief Tech/Sci/R&D Officer | 10/12/2020 |
Shanghai Miracogen, Inc.
Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The private company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Corporate Officer/Principal | - |
Precedenti posizioni note di Min MIn Qin
Società | Posizione | Fine |
---|---|---|
HBM HOLDINGS LIMITED | Corporate Officer/Principal | 01/04/2019 |
WUXI BIOLOGICS (CAYMAN) INC. | Corporate Officer/Principal | 01/03/2018 |
Jiangsu Pacific Meinuoke Pharmaceutical Co. Ltd. | Chief Tech/Sci/R&D Officer | 01/07/2017 |
Zhejiang Teruisi Pharmaceutical Co., Ltd.
Zhejiang Teruisi Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Zhejiang Teruisi Pharmaceutical Co., Ltd. is a private company based in Zhejiang, China that engages in the production of cancer medicine. | Chief Tech/Sci/R&D Officer | 01/10/2016 |
Shanghai JMT-BIO Technology Co., Ltd. | Chief Tech/Sci/R&D Officer | 01/09/2015 |
Formazione di Min MIn Qin
University of Wisconsin | Doctorate Degree |
Northwest A&F University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
HBM HOLDINGS LIMITED | Health Technology |
LEPU BIOPHARMA CO., LTD. | Health Technology |
Aziende private | 5 |
---|---|
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
Shanghai JMT-BIO Technology Co., Ltd. | |
Shanghai Miracogen, Inc.
Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The private company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Health Technology |
Zhejiang Teruisi Pharmaceutical Co., Ltd.
Zhejiang Teruisi Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Zhejiang Teruisi Pharmaceutical Co., Ltd. is a private company based in Zhejiang, China that engages in the production of cancer medicine. | Health Technology |
Jiangsu Pacific Meinuoke Pharmaceutical Co. Ltd. |